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Abstract   
Aim - To determine the effect of exercise training on clinical events and health-related 
quality of life (HRQoL) of patients with systolic heart failure.  
Methods & Results - We searched electronic databases including Medline, EMBASE and 
Cochrane Library up to January 2008 to identify randomised controlled trials (RCTs) 
comparing exercise training and usual care with a minimum follow up of 6-months. Nineteen 
RCTs were included with a total of 3,647 patients, the majority of whom were male, low to 
medium risk, New York Heart Association class II to III with a left ventricular ejection 
fraction of < 40%.  There was no significant difference between exercise and control in short-
term (≤ 12 months) or longer term all cause mortality or overall hospital admissions. Heart 
failure related hospitalisations were lower (relative risk: 0.72, 95% CI: 0.52 to 0.99) and 
HRQoL improved (Standardised mean difference: -0.63, 95% CI:-0.80 to -0.37) with exercise 
therapy. Any effect of cardiac exercise training on total mortality and HRQoL was 
independent of degree of left ventricular dysfunction, type of cardiac rehabilitation, dose of 
exercise intervention, length of follow-up, trial quality, and trial publication date. 
Conclusion - Compared to usual care, in selected heart failure patients, exercise training 
reduces heart failure-related hospitalisations and results in clinically important improvements 
in HRQoL.  High quality RCT and cost effectiveness evidence is needed of the effect of 
exercise training in community based settings and in more severe heart failure patients, 





Patients with chronic heart failure (CHF) experience marked reductions in their exercise 
capacity which has detrimental effects on their activities of daily living, health-related quality 
of life (HRQoL) and ultimately their hospital admission rate and mortality.1  
 
Exercise training is often a component of rehabilitation programmes offered to patients with 
CHF.1 In 2004, a Cochrane systematic review by Rees et al on the effect of exercise-based 
interventions on people with heart failure demonstrated a clear improvement in short-term 
exercise capacity.2 Twenty nine trials were included in that review, only one of which 
reported longer-term hospitalisations and mortality. The remaining trials were largely small 
scale and did not aim to assess clinical events. The ExTraMATCH Collaborative Group 
published, also in 2004, an individual patient data meta-analysis.3 This review reported a 
reduction in the mortality of CHF patients who received exercise based intervention (hazard 
ratio 0.65, 95% CI 0.46 to 0.92). However, the ExTraMATCH study was based on a limited 
bibliographic literature search (Medline plus hand-searching of selected leading cardiac 
journals) and included unpublished data. It has therefore been difficult to verify the data and 
comprehensiveness of this meta-analysis; several of the trials included in the Cochrane 
review were not included in the ExTraMATCH review. Reanalysis of the ExTraMATCH trial 
data using meta-analytic methods has shown that the effect of exercise-training was not 
statistically significant when compared to control (relative risk 0.88, 95% CI: 0.70 to 1.10).4 
Van Tol and colleagues, in 2006, published a meta-analysis supporting the improvements in 
exercise capacity as seen in the previous Cochrane review.5 They also saw an improvement in 
quality of life as measured by the Minnesota Living with Heart Failure (MLWHF) 
Questionnaire. In 2007, Hawkowsky et al published a systematic review demonstrating the 
positive effect of exercise based intervention on cardiac remodeling in patients with CHF.6 In 
summary, to date, there is consensus on the positive effect of exercise on exercise capacity 
but the effects on hospital admission rates, mortality and HRQoL remains uncertain.  
 
The aim of the present study was to determine the impact of exercise based interventions on 






The review was undertaken in accord with the methods of The Cochrane Collaboration.7 
 
Study Selection 
Previous meta-analyses and systematic reviews were searched for studies.2-5,8-10 The 
following electronic databases were searched from searching end date of the previous 
Cochrane systematic review (2001) and up to January 2008: Cochrane Central Register of 
Controlled Trials (CENTRAL) in The Cochrane Library, EMBASE, MEDLINE, CINAHL, 
PsycINFO, the NHS Centre for Reviews and Dissemination (CRD) databases (Health 
Technology Assessment (HTA) and Databases of Abstracts of Reviews of Effects (DARE)). 
Conference proceedings were searched on Web of Science: ISI Proceedings. Using search 
filters were limited to randomised controlled trials (RCTs), systematic reviews, and meta-
analyses and humans. The search was designed as part of broader review that included the 
update of number of cardiac rehabilitation reviews (see Appendix 1).  No language or other 
limitations were imposed. Two reviewers independently scanned all the titles and abstracts 
and identified potentially relevant articles to be retrieved. Where there was uncertainty, full-
text copies of papers were obtained. 
 
Inclusion and exclusion criteria 
Studies were considered eligible if they were RCTs; included CHF patients (> 18 years) with 
either ischaemic or non-ischaemic aetiology and specified criteria for the diagnosis of 
systolic heart failure such as an objective assessment of left ventricular ejection fraction or by 
clinical findings; received an exercise based intervention either alone or as part of a 
comprehensive cardiac rehabilitation program (defined as programs also including such 
components as health education and psychological treatment); compared to standard medical 
care or attention placebo control group, and with a minimum follow up of six months. Four 
categories of outcome were sought: mortality (all cause, death due to heart failure and sudden 
cardiac death); hospital admission/re-admission rates and HRQoL assessed by a validated 
outcome measure (e.g. Minnesota Living with Heart Failure [MLWHF] Questionnaire or 
Short-Form 36 [SF-36]); and cost effectiveness.  Trials recruiting patients with heart failure 
associated with normal systolic function were excluded as were studies that included patients 
who had previously been offered cardiac rehabilitation. Full-text papers of all potentially 
eligible trials were independently assessed by two reviewers and disagreements were 




Data extraction and risk of bias assessment 
The following information categories were extracted: details of the study population and their 
baseline characteristics; details of the intervention (exercise training prescription and co-
interventions) and control; length of follow-up; and details of individual outcome results.  In 
order to assess of risk of bias, the following factors were considered: appropriate method of 
randomisation (e.g., statement of computer-generated numbers) sequence, and an adequate 
concealment of randomisation (e.g., randomisation codes been kept from those involved in 
running the trial), whether there was blinding (particularly blinding of outcome given the 
difficulties of blinding patients and carers given the nature of the intervention), whether all 
outcomes and losses to follow up/drop-outs were reported and whether intention to treat 
analysis was performed.7 Study authors were contacted to seek clarification on issues of 
reporting or to provide further outcome detail. Data extraction and risk of bias assessment 
was undertaken by a single reviewer using a standardised form and verified by a second 
reviewer.   
 
Statistical analysis 
Dichotomous outcomes were expressed as relative risks (RR) and 95% confidence intervals 
(CI) were calculated. Net changes in continuous variables were compared (i.e. exercise based 
intervention minus control group differences) and a weighted mean difference (WMD) or 
standardised mean difference (SMD) together with 95% CI expressed for each study.7 
Heterogeneity amongst included studies was explored qualitatively (with comparison of the 
characteristic of included studies) and quantitatively (using the chi-squared test of 
heterogeneity and I2 statistic). A fixed-effects meta-analysis was used except when statistical 
heterogeneity was identified when the more conservative random-effects model was used.11 
In studies reporting more than one HRQoL outcome, to prevent double counting in meta-
analysis, we chose one of the reported HRQoL outcomes at random. The inference of meta-
analysis did not change when selecting the alternative HRQoL measure score. Sensitivity 
analysis was undertaken to examine the effect of omission of HF-ACTION trial.xxii Meta-
regression was used to examine the influence of a number of factors on all cause mortality 
and HRQoL. The study level factors included: mean left ventricular ejection fraction; dose of 
exercise intervention (‘dose’ was calculated as the number of weeks multiplied by the 
number of sessions per week, multiplied by the duration of the session in hours); type of 
exercise (aerobic training alone or aerobic plus resistance training); type of cardiac 
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rehabilitation (exercise-based cardiac rehabilitation vs. comprehensive cardiac rehabilitation); 
mean age; gender (% male); setting (hospital only, both hospital and home or home only); 
and duration of follow-up. In order to assess the potential effect of a change in the standard of 
usual care over time we added year of publication as an additional study level factor (pre- vs. 
post 2000) to reflect when beta-blockers, angiotensin-receptor blockers and angiotensin-
converting enzyme inhibitors became established therapies for CHF.12 Funnel plots (i.e. 
scatter plots of the mean intervention effect versus the inverse of variance of the intervention 
effect for each study) were used to explore the possibility of publication bias. 13 All analyses 





Identification and selection of studies 
Our bibliographic search yielded 11,561 titles. After a review of the titles and abstracts of 
these, 65 full papers were retrieved and assessed. In total 50 papers were excluded: 19 with 
follow up less than 6 months, 21 with outcomes not relevant to this review (e.g. exercise 
capacity), three with an inappropriate study population and six were reviews and one was a 
study protocol. Therefore the total number of included trials was 19 (23 papers) (See Figure 
1). One trial was split into two sub-studies to reflect that the included patients were 
randomised to two different exercise interventions, both compared to usual care.xv The 
protocol of the HF-ACTION trialxxii was identified by our search and so the trial was 
included, despite it being published after January 2008.  
 
Description of randomised controlled trials 
The 19 trials contained a total of 3,647 patients, some 60% of which were contributed by the 
HF-ACTION trial v, xiv (N=2,331) (see Table 1). Recruited subjects were mainly 
uncomplicated CHF patients with NHYA class II and III and a left ventricular ejection 
fraction of less than 40%. Mean age ranged from 43 to 72 years and the majority was male 
(43 to 100%). With one exception, all trials were judged to be exercise-only interventions. In 
addition to exercise training, Austin et al provided patients with education and psychological 
interventions (i.e. comprehensive cardiac rehabilitation).i,ii All studies used the modality of 
aerobic training with five also using resistance training. Exercise training programmes ranged 
widely across the studies: duration - 15 to 120 minutes per session, frequency - 2 to 7 
sessions/week, intensity - 40% maximum heart rate to 85% of maximum oxygen uptake 
(VO2max), overall duration - 24 weeks to 3-years. Exercise was centre delivered in 12 
studies, entirely home based in one study and initially within centre and then at home in the 
remainder. Both intervention and control patients received usual care including medication 
and education advice, although controls received no formal exercise training. Four trials 
reported a follow up longer than 12 months.ii,iiii,xviii,xix  
 
Risk of bias 
A number of studies failed to give sufficient detail to assess their potential risk of bias (Table 
2). Details of generation and concealment of random allocation sequence and intention to 
treat analysis were particularly poorly reported. Only the studies of Austin et ali, Hambrecht 
et al,xii McKelvie et alxvii and the HF-ACTION trialxxii provided an adequate description of the 
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randomisation process. Nevertheless, in none of the studies was there objective evidence of 
imbalance in baseline characteristics.  Four trials stated that they performed intention to treat 
analysis.i, vi,xiii,xix However, although often not stated, many studies appeared to compare 
exercise and control group outcomes according to initial random allocation. Where reported, 
losses to follow up varied considerably across studies and the impact of losses to follow up or 
drop out was only examined in a few trials. Only the studies of Koukovou et al,xvi McKelvie 
et al,xvii and Willenheimer et alxxiii reported blinding of outcome assessment.  
 
Outcomes 
Pooled outcome findings are summarised in Table 3. 
Mortality 
There was no difference in pooled all-cause mortality between the exercise based 
intervention and control groups up to 12-months follow up (RR: 1.02, 95% CI: 0.70 to 1.51, 
heterogeneity chi-squared = 3.89, p = 0.952, Figure 2) or when pooling the four trials with 
follow up of longer than 12-months (RR 0.91, 95% CI: 0.78 to 1.06, heterogeneity chi-
squared = 5.06, p = 0.167, e-Figure 1). A significant reduction in longer term mortality was 
seen with exclusion of HF-ACTION trial (RR: 0.62, 95% CI: 0.39 to 0.98). There is a lack of 
consistency in reporting deaths due to heart failure or sudden cardiac death.  
Hospital Admissions 
Whilst there was weak evidence of a trend towards a reduction in the overall hospital 
admission rate up to 12-months (RR 0.79, 95% CI: 0.58 to 1.07, heterogeneity chi-squared = 
5.07, p = 0.535, e-Figure 2) there was no evidence of an effect beyond 12 months (RR 0.96, 
95% CI: 0.90 to 1.02, heterogeneity chi-squared = 4.74, p = 0.192, e-Figure 3). This longer 
term result was consistent with the exclusion of HF-ACTION (RR: 0.75, 95% CI: 0.52 to 
1.08). There was a significant reduction in heart failure specific hospital admissions with 
exercise-based interventions (RR: 0.72, 95% CI: 0.52 to 0.99, heterogeneity chi-squared = 
7.17, p = 0.305,e-Figure 3). 
HRQoL 
Ten studies assessed HRQoL using a validated scale. Most used the disease specific 
Minnesota Living with Heart Failure (MLWHF) scale, others included scales were EuroQoL 
(EQ-5D), Psychological Wellbeing Index (PGWB), Patients Global Assessment of Quality of 
Life (PGAQoL), Spritzer’s Quality of Life Index (QLI) and the recently developed Kansas 
City Cardiomyopathy Questionnaire (KCCQ). The study by Gottleib only reported HRQoL 
values at follow up in the exercise group but not the controls (see e-Table 1).ix Across the five 
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studies that reported total MLWHF score, there was strong evidence of improvement with 
exercise (mean difference: -10.3, 95% CI: -15.9 to -4.8, heterogeneity chi-squared =  17.49, p 
= 0.004, e-Figure 4). Pooling across all studies regardless of the HRQoL measure used, there 
was also strong evidence of improvement with exercise (standardised mean difference: -0.57, 
95% CI: -0.83 to -0.31, heterogeneity chi-squared = 45.03, p<0.0001, Figure 4); a finding 
that remained on exclusion of HF-ACTION (standardised mean difference: -0.63, 95% CI: -
0.89 to-0.37).  
Cost Effectiveness 
Only the Belardinelli trial reported a cost effectiveness analysis.viii Fourteen-month survival 
and healthcare costs were extrapolated to 15.5 years and incremental cost per life year gained 
ratio for exercise-based intervention versus controls were compared. The estimated 
incremental cost for the exercise-based intervention group, $US 3,227/patient, was calculated 
by subtracting the averted hospitalisation cost, $US 1,336/patient, from the cost of exercise 
training and wage lost due to exercise training estimated at $US 4,563/patient. For patients 
receiving exercise training, the estimated increase in life expectancy was 1.82 years/person in 
a time period of 15.5 years, compared with patients in the control group. The cost 
effectiveness ratio for long-term exercise in patients was determined at $US 1,773/life-year 
saved, at a 3% discount rate at 1999 costs.  
 
Meta-regression 
Univariate meta-regression analyses showed no evidence of a relationship between the effect 
of exercise training and all-cause mortality and any of the covariates. There was a 
significantly (P=0.04) larger improvement in HRQoL with exercise training in trials in a 
centre-setting compared to a home-setting. No other covariates were related to the effect of 
exercise training on HRQoL  (see Table 4).  
 
Small study bias 
Whereas there was no evidence of funnel plot asymmetry for either all-cause mortality (e-
Figure 5) and overall hospitalisations ( e-Figure 6), the funnel plot for HRQoL outcomes did 
demonstrate asymmetry ( e-Figure 7). Given the statistically significant small study bias seen 
with HRQoL, regression based adjustment was applied and it was found that improvement in 








This systematic review shows that in systolic CHF patients, exercise-based intervention 
reduces the level of hospitalisations due to heart failure and improves HRQoL. We identified 
trials which consistently reported higher levels of HRQoL. In those using the Minnesota 
Living with Heart Failure (MLWHF) questionnaire, exercise intervention groups were on 
average 10 points higher than controls. A difference of 4 points has been shown to represent a 
clinically important and meaningful difference for the patient.15 The HRQoL effects of 
exercise therapy appears to be consistent across a number of CHF groups (i.e. age, gender 
and left ventricular ejection fraction) as well as range of exercise intervention delivery 
strategies (exercise dose, aerobic only exercise versus aerobic plus resistance exercise, and 
exercise only versus comprehensive cardiac rehabilitation). We found no evidence that 
exercise training either increases or decreases all cause mortality.  
 
Comparison with previous systematic reviews 
Most previous systematic reviews of exercise training for heart failure identified insufficient 
number of deaths and hospitalisations to reliably comment on these outcomes. 2-5,8-10 
However, our finding of a statistically non-significant difference in all cause mortality with 
exercise training versus control is consistent with the reanalysis of individual patient data 
meta-analysis of the ExTraMATCH Collaborative.4 More recent trials have been conducted 
in the context of optimal medical therapy. For example, at entry to the ACTION-HF trial 
94% of patients were receiving beta-blockers and angiotension-receptor blockers or 
angiotensin-converting enzyme inhibitors.xxii Forty-five percent had an ICD or biventricular 
pacemaker implanted at the time of enrolment. Given the proven survival advantage of these 
medical treatments12, any incremental all-cause mortality benefit with exercise is therefore 
likely to be small. Based on the observed levels of mortality seen in four trials with long term 
follow upii,iii,xviii,xxii, a total of some 12,000 patients would need to be randomised to exercise-
based cardiac rehabilitation or usual care to demonstrate a statistically significance benefit of 
exercise (at 5% alpha and 80% power).  
 
The improvements seen in HRQoL with exercise training are in accordance with the previous 
systematic review of van Tol and colleagues.5 The recent systematic review of Chein 
concluded that home-based exercise training does not improve the HRQoL of heart failure 
patients.10 Eight of the trials included in this review combined an initial period of supervised 
hospital based exercise training followed by a home-based programme.i,vii,x,xi,xii,xvii, xix,xx Only 
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one included study assessed an entirely home-based programme.ix Although we found a 
larger  improvement in HRQoL with exercise training in those studies based solely in a 
hospital setting, there was a significant improvement in HRQoL compared to control in  
home-based exercise intervention studies.  
 
Mechanism of action 
The precise mechanism through which exercise-based interventions benefits CHF remains 
unclear. One explanation, applicable to patients with ischaemic cardiomyopathy, is that 
exercise improved myocardial perfusion by alleviating endothelial dysfunction and therefore 
dilating coronary vessels and by stimulating angiogenesis by way of intermittent ischaemia.3 
Ventricular remodeling has been shown to be attenuated by exercise training.6 Indeed, 
Belardinelli et al have demonstrated that aerobic training improves myocardial contractility 
and diastolic filling.16 Regardless of the cause, there are important neurohormonal and 
musculoskeletal abnormalities in heart failure.3 Exercise training may reduce adrenergic tone 
and increase vagal tone, as suggested by an assessment of variability of heart rate. Skeletal 
muscle dysfunction and wasting may also respond to exercise training. Hambrecht et al have 
demonstrated that regular physical activity in chronic heart failure patients stimulates 
vasodilatation in the skeletal muscle vasculature.17 
 
Study limitations 
Although we believe this to be the most comprehensive systematic review of RCT-based 
evidence for the impact of exercise-based intervention on patients with heart failure to date, 
we acknowledge that this review has a number of limitations. The general lack of reporting 
methods in the included RCTs made it difficult to assess their methodological quality and 
thereby judge their risk of bias and potential to overestimate the effect of exercise-based 
interventions. However, they do not appear to be sensitive to risk of bias criteria such as 
intention to treat analysis and outcome bias. Although a specific goal of this review was to 
clarify the impact of exercise based interventions on clinical events, many included trials 
were relatively small and of short term follow up and there were low numbers of deaths and 
hospitalisations reported by the majority of the trials. In many of the studies, we identified 
event data in the trial descriptions of losses to follow up and exclusions rather that reported 
outcomes per se. Most included studies were in low to moderate risk males and included 
predominately (43-100%) patients with NYHA class II to III and LVEF less than 40%, with a 
mean age of participants across studies ranging from 43 to 72 years. The generalisability of 
13 
 
our findings may therefore be limited. Although the majority of evidence in this review 
comes from the recently reported HF-ACTION  studyxxii, the findings of previous trials 
appear consistent with this important trial.   
 
To improve generalisability, future exercise intervention trials should include more severe 
CHF patients, elderly people and women and be sufficiently large and of long enough 
duration to accrue meaningful numbers of clinical outcomes and report these outcomes by 
key patient subgroups (e.g. atrial fibrillation, diabetes mellitus). There is a need to examine 
more community or home-based exercise intervention programmes and how such 
programmes can be most clinically and cost effectively integrated alongside current models 
of service delivery. Few of the included studies reported the actual level of exercise training 
undertaken by participants. Notably, the HF-ACTION study where only approximately 30% 
patients randomised to exercise training exercised at or above their exercise prescription.xxii 
Future studies therefore need to consider interventions to enhance the long term adherence to 





Compared to usual care, in low to moderate risk NYHA class II and III systolic heart failure 
patients, exercise-based intervention reduces heart failure-related hospitalisations and results 
in clinically important improvements in HRQoL. Exercise training did not reduce or increase 
all cause mortality. Any effect of cardiac exercise training on total mortality and HRQoL was 
were independent of degree of left ventricular dysfunction, type of cardiac rehabilitation, 
dose of exercise intervention, length of follow-up, trial quality, and trial publication date. 
High quality RCT and cost effectiveness evidence is needed to assess the effect of exercise 
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Appendix 1. Example search strategy 
 
MEDLINE DIALOG 1950-WEEK 1 2008 
1. search: myocardial-ischemia#.de. 
2. search: myocard$4 near (ischaemi$2 or ischemi$2) 
3. search: (ischaemi$2 or ischemi$2) near heart 
4. search: coronary-artery-bypass#.de. 
5. search: coronary.ti,ab. 
6. search: coronary-disease#.de. 
7. search: myocardial-revascularization#.de. 
8. search: myocardial-infarction#.de. 
9. search: myocard$5 near infarct$5 
10. search: heart near infarct$5 
11. search: angina-pectoris#.de. 
12. search: angina.ti,ab. 
13. search: heart-failure-congestive#.de. 
14. search: heart near failure 
15. search: 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 
16. search: heart-diseases#.de. 
17. search: (heart near disease$2).ti,ab. 
18. search: myocard$5.ti,ab. 
19. search: cardiac$2.ti,ab. 
20. search: cabg 
21. search: ptca 
22. search: stent$4 and (heart or cardiac$4) 
23. search: heart-bypass-left#.de. or heart-bypass-right#.de. 
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